After hours: January 31 at 5:01:33 PM EST Loading Chart for IGMS ...

JPMorgan upgraded IGM Biosciences (IGMS) to Neutral from Underweight without a price target The firm says that with the company announcing discontinuation of imvotamab development alongside a ...

Stifel downgraded IGM Biosciences (IGMS) to Hold from Buy with a price target of $2.50, down from $27. Th firm cites the company’s “surprising decision” to discontinue all further ...

Late this week, a quartet of companies—IGM Biosciences, Y-mAbs Therapeutics, Passage Bio and Shoreline Biosciences—each revealed plans to cut jobs as they rework their respective pipelines and ...

The business is stopping further research on imvotamab, a CD20 x CD3 bispecific antibody, and IGM-2644, a CD38 x CD3 bispecific antibody. Phase 1b rheumatoid arthritis and systemic lupus ...

At the moment, the best Steam Deck dock I've tested is the Baseus 6-in-1 docking station. It offers a nice selection of ports for the price, but the feature that makes it stand out is its ...

For many years, the potential of immunoglobulin M (IgM) antibodies was not fully understood because of characteristics different to the well-known immunoglobulin G type like low target affinity, cross ...

To get a feel for Kennebunkport's personality, spend an afternoon in Dock Square. This neighborhood – nestled in the center of town – bustles with boutique shoppers and art gallery-hoppers ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...